Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Healthbook TIMES Oncology Hematology is Scopus-indexed (Q4, CiteScore 0.8), DOAJ. Published by The HealthBook Company Ltd.
Checked against the index lists dated .
ISSN 2673-2092Verify ISSN ↗2673-2106Verify ISSN ↗
Publisher: The HealthBook Company Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 122 / 151 | 19th | Q4 |
| Oncology | 352 / 428 | 17th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q4, CiteScore 0.8.
Healthbook TIMES Oncology Hematology is Q4 in Hematology (rank 122 of 151) and Q4 in Oncology (rank 352 of 428), by CiteScore 2025.
Healthbook TIMES Oncology Hematology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q4, 19th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.157, quartile Q4, with an H-index of 4.
Healthbook TIMES Oncology Hematology is published by The HealthBook Company Ltd. Its print ISSN is 2673-2092 and its online ISSN is 2673-2106.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Healthbook TIMES Oncology Hematology has an h-index of 4 and a 2-year mean of 0.35 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #120 of 148 Scopus journals in Hematology.
Healthbook TIMES Oncology Hematology published 26 papers in 2025; its busiest recent year was 2024 with 43. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 78 research articles (2023–2026), authors are most often from Switzerland (82.5%), Austria (6.4%) and United States (5.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.